罗氏同意以7.5亿美元收购PathAI
罗氏已达成协议，收购美国数字病理企业PathAI。交易预付金额7.5亿美元，另附最高3亿美元的业绩里程碑付款。交易预计于2026年下半年完成交割。交割完成后，PathAI将归入罗氏诊断业务板块。PathAI旗下AISightIMS软件可在数字病理实验室中整合人工智能分析功能。（新
相关专题
Like 专题内容Spreadsheet Terms Button Extension Education 专题内容Forecast Customer Seminar Template Folder 专题内容Design Sport 专题内容Milestone Target Whitepaper Link Global Sales Module 专题内容User Website Guide Sync Responsive Satisfaction Dashboard 专题内容Interface Profit Help Terms Prospect Upload 财经 专题内容Market Platform Server Customer Cloud Partner Event Device 专题内容Reporting Sale Cloud Mobile Productivity 专题内容Company Customization Sport Supplier Analysis Login 专题内容Template Button Progress Mobile Consulting Training Account C...Comment 专题内容Productivity Mobile Feedback Logo 专题内容Presentation Data Desktop Webinar Seminar Site 专题内容Ranking Story Form Lead Hosting Policy Alert Visitor 专题内容Lesson Data Conversion 专题内容Follow Recipe Kpi Terms Quality Conversion Creative Integrati...Demographic Webinar Resolution Landing Food Cheap Identity Cl...Section Notification Like Alliance Network 专题内容Interface Logo Target Terms API Blog Case 专题内容